Tolerability of Grazax-R in Children
This study has been completed.
Information provided by:
First received: March 1, 2006
Last updated: May 3, 2006
Last verified: May 2006
This trial is performed to assess whether the Grazax-R treatment is safe to use in children aged 5-12 years.
|Study Design:||Allocation: Randomized
Endpoint Classification: Safety Study
Intervention Model: Parallel Assignment
|Official Title:||A Randomised, Double-Blind, Placebo-Controlled, Multi-Centre Phase I Trial Investigating the Safety of GRAZAX-R in Children Aged 5-12 Years With Grass Pollen Induced Rhinoconjunctivitis (With/Without Asthma)|
Resource links provided by NLM:
Further study details as provided by ALK-Abelló A/S:
Contacts and Locations